| Literature DB >> 33784843 |
Tayierjiang Yasheng1, Aini Mijiti2, Maimaiaili Yushan1, Zhenhui Liu1, Yanshi Liu1, Aihemaitijiang Yusufu1.
Abstract
OBJECTIVE: Ozone is a colorless gas used as a disinfectant and to treat diseases by limiting the effects of bacteria, viruses, fungi, yeast, and protozoa. In this study, we investigated the clinical efficacy of ozonated water lavage and physiological saline irrigation combined with vacuum-sealed drainage (VSD) in the treatment of chronic osteomyelitis.Entities:
Keywords: Chronic osteomyelitis; efficacy; irrigation; ozonated water; traditional medullary cavity irrigation; vacuum-sealed drainage
Mesh:
Substances:
Year: 2021 PMID: 33784843 PMCID: PMC8020234 DOI: 10.1177/0300060521999530
Source DB: PubMed Journal: J Int Med Res ISSN: 0300-0605 Impact factor: 1.671
Figure 1.The patient was a 34-year-old man with a traumatic fracture. (a, b) The images show a complex open fracture of the right femur with a bone defect and an open fracture of the right tibia and fibula with vascular and nerve damage. The right tibia was amputated below the knee. (c, d) An osteotomy was performed to shorten the tibial amputation site, and part of the amputated tibia was used for mid-femoral bone grafting. X-ray images show the femur 16 months later. (e, f) After 17 months, traditional intramedullary canal irrigation and drainage was performed. X-ray images show the femur 18 months after the initial surgery.
Figure 2.The same patient as in Figure 1, 19 months after injury. Ozonated water irrigation and physiological saline lavage were applied in combination with VSD treatment. (a–e) The first operation. (f) The fourth operation.
The patients’ detailed demographic data.
| Case No. | Gender | Age (years) | Cause of injury | Location | Follow-up time (months) |
|---|---|---|---|---|---|
| 1 | Male | 9 | hematogenous | femur | 22 |
| 2 | Male | 11 | hematogenous | tibia | 19 |
| 3 | Female | 13 | hematogenous | tibia | 18 |
| 4 | Female | 11 | hematogenous | tibia | 20 |
| 5 | Male | 25 | traumatic | femur | 20 |
| 6 | Male | 43 | traumatic | femur | 18 |
| 7 | Male | 34 | traumatic | femur | 84 |
| 8 | Male | 52 | traumatic | humerus | 29 |
| 9 | Male | 36 | traumatic | tibia | 26 |
| 10 | Male | 26 | traumatic | tibia | 35 |
| 11 | Male | 48 | traumatic | tibia | 41 |
| 12 | Male | 43 | traumatic | tibia | 32 |
| 13 | Female | 29 | traumatic | tibia | 18 |
| 14 | Male | 27 | traumatic | tibia | 24 |
| 15 | Female | 49 | traumatic | tibia | 28 |
| 16 | Male | 35 | traumatic | tibia | 46 |
| 17 | Male | 40 | traumatic | tibia | 40 |
| 18 | Male | 27 | traumatic | tibia | 38 |
Figure 3.The same patient as in Figure 1 20 months (a, b), 3 years (c, d), and 7 years (e, f) after initial treatment.